论文信息 - A Phase 1a/b Dose Escalation Study of the MYC Repressor Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS - 字舞流文

A Phase 1a/b Dose Escalation Study of the MYC Repressor Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS

R. Bejar | S. Howell | W. Rice | Hongying Zhang | N. Rastgoo | M. Thayer | K. Benbatoul | Yuying Jin | Jotin Marango | V. Montalvo‐Lugo | Susan Sheng | Gregory k Chow